12-98534325-C-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The ENST00000266732.8(TMPO):​c.2068C>T​(p.Arg690Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00437 in 1,612,356 control chromosomes in the GnomAD database, including 441 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R690H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0060 ( 44 hom., cov: 33)
Exomes 𝑓: 0.0042 ( 397 hom. )

Consequence

TMPO
ENST00000266732.8 missense

Scores

1
2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:9

Conservation

PhyloP100: 0.469
Variant links:
Genes affected
TMPO (HGNC:11875): (thymopoietin) Through alternative splicing, this gene encodes several distinct LEM domain containing protein isoforms. LEM domain proteins include inner nuclear membrane and intranuclear proteins, and are involved in a variety of cellular functions including gene expression, chromatin organization, and replication and cell cycle control. The encoded alpha isoform is broadly diffuse in the nucleus and contains a lamin binding domain, while the beta and gamma isoforms are localized to the nuclear membrane and contain an HDAC3 interaction domain. The distinct isoforms may compete with each other when acting to chaperone other proteins and regulate transcription. [provided by RefSeq, Aug 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014022291).
BP6
Variant 12-98534325-C-T is Benign according to our data. Variant chr12-98534325-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 12707.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=6}. Variant chr12-98534325-C-T is described in Lovd as [Pathogenic]. Variant chr12-98534325-C-T is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TMPONM_001032283.3 linkuse as main transcriptc.565+2487C>T intron_variant ENST00000556029.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TMPOENST00000556029.6 linkuse as main transcriptc.565+2487C>T intron_variant 1 NM_001032283.3 P42167-1

Frequencies

GnomAD3 genomes
AF:
0.00596
AC:
907
AN:
152130
Hom.:
44
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0480
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00404
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000706
Gnomad OTH
AF:
0.0110
GnomAD3 exomes
AF:
0.0188
AC:
4648
AN:
247860
Hom.:
354
AF XY:
0.0141
AC XY:
1897
AN XY:
134596
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.127
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00508
Gnomad SAS exome
AF:
0.000262
Gnomad FIN exome
AF:
0.00169
Gnomad NFE exome
AF:
0.000444
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.00420
AC:
6134
AN:
1460108
Hom.:
397
Cov.:
32
AF XY:
0.00356
AC XY:
2584
AN XY:
726408
show subpopulations
Gnomad4 AFR exome
AF:
0.000866
Gnomad4 AMR exome
AF:
0.116
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00856
Gnomad4 SAS exome
AF:
0.000186
Gnomad4 FIN exome
AF:
0.00177
Gnomad4 NFE exome
AF:
0.000248
Gnomad4 OTH exome
AF:
0.00323
GnomAD4 genome
AF:
0.00599
AC:
912
AN:
152248
Hom.:
44
Cov.:
33
AF XY:
0.00605
AC XY:
450
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.00152
Gnomad4 AMR
AF:
0.0482
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00405
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00151
Gnomad4 NFE
AF:
0.000706
Gnomad4 OTH
AF:
0.0109
Alfa
AF:
0.00189
Hom.:
14
Bravo
AF:
0.0116
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000909
AC:
4
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.0148
AC:
1801
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 18, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, no assertion criteria providedclinical testingStanford Center for Inherited Cardiovascular Disease, Stanford UniversitySep 16, 2014Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Arg690Cys (c.2068 C>T) in TMPO (NM_003276.2) This variant has been seen previously with DCM (Taylor et al 2005). However, it was also seen in 13 of 60 indiviudals of Mexican ancestry in 1000 genomes including two homozygous individuals. Our team recently reviewed the evidence that TMPO is implicated in cardiomyopathy and found it to be weak. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineOct 19, 2012Arg690Cys in exon 4 of TMPO: This variant is not expected to have clinical signi ficance because it has been identified in 11.7% (15/128) of Mexican American chr omosomes from a broad population by the 1000 Genomes project (dbSNP rs17028450). This variant has been previously reported in 2 siblings with DCM (Taylor 2005). -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 20, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Dilated cardiomyopathy 1T Uncertain:2
Uncertain significance, no assertion criteria providedliterature onlyOMIMDec 01, 2005- -
Uncertain significance, criteria provided, single submitterreference populationSoonchunhyang University Bucheon Hospital, Soonchunhyang University Medical CenterMar 18, 2016- -
TMPO-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 10, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 22, 2023- -
Loeys-Dietz syndrome 2 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Primary dilated cardiomyopathy Benign:1
Likely benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Hypertrophic cardiomyopathy 25 Benign:1
Benign, criteria provided, single submitterresearchBroad Center for Mendelian Genomics, Broad Institute of MIT and Harvard-The heterozygous p.Arg690Cys variant in TCAP has been identified in at least 2 siblings with dilated cardiomyopathy (PMID: 16247757). In vitro functional studies provide some evidence that the p.Arg690Cys variant may slightly impact protein function (PMID: 16247757). However, these types of assays may not accurately represent biological function. This variant is classified as benign for autosomal dominant dilated cardiomyopathy because it has been identified in >14% of Latino chromosomes and 141 total homozygotes by ExAC (http://gnomad.broadinstitute.org/). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.10
T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.21
FATHMM_MKL
Benign
0.52
D
LIST_S2
Benign
0.57
T
MetaRNN
Benign
0.0014
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.0
L
MutationTaster
Benign
0.94
A;A;A;A;A
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.66
N
REVEL
Benign
0.23
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.010
B
Vest4
0.082
MPC
0.091
ClinPred
0.029
T
GERP RS
1.7
Varity_R
0.15
gMVP
0.058

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17028450; hg19: chr12-98928103; API